Figure 4.
Sensitivity analysis confirming consistent Risankizumab effects on (a) clinical remission, (b) clinical response, and (c) endoscopic remission, with significance maintained across all study removals.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.